News & Analysis as of

Personalized Medicine Biologics

Foley & Lardner LLP

More Than 25% of New Molecular Entities Approved in 2016 Are Personalized Medicines

Foley & Lardner LLP on

The Personalized Medicine Coalition (PMC) recently reported that for the third year in a row, personalized medicines accounted for more than 25% of all new molecular entities (NMEs) approved by the US Food & Drug...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide